SCHEMBL30457953

SCHEMBL30457953

O=C1NC(=S)N(c2cccc(F)c2)C(=O)C1=Cc1ccco1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 15/20 0.78
KMT2A Q03164 15/20 0.78
POLB P06746 11/20 0.78
BLM P54132 7/20 0.78
USP2 O75604 4/20 0.78
CACNA1B Q00975 2/20 0.78
APBA1 Q02410 2/20 0.78
PPP1CA P62136 1/20 0.78
GAA P10253 5/20 0.75
DNMT1 P26358 2/20 0.75
L3MBTL1 Q9Y468 2/20 0.70
NSD2 O96028 1/20 0.70
CTDSP1 Q9GZU7 1/20 0.70
ALPL P05186 1/20 0.64
ALPI P09923 1/20 0.64
ALPG P10696 1/20 0.64
GRK2 P25098 1/20 0.64
GALK1 P51570 1/20 0.60
KCNH2 Q12809 1/20 0.60
ITGA4 P13612 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25633644 1.00 MEN1 (0.78) MEN1KMT2APOLBBLMUSP2
SCHEMBL14777540 0.88 MEN1 (0.77) MEN1KMT2APOLBBLMUSP2
SCHEMBL2493582 0.88 MEN1 (0.77) MEN1KMT2APOLBBLMUSP2
SCHEMBL29504051 0.87 MEN1 (0.75) MEN1KMT2APOLBBLMUSP2
SCHEMBL29504050 0.87 MEN1 (0.75) MEN1KMT2APOLBBLMUSP2
SCHEMBL22396433 0.87 MEN1 (0.75) MEN1KMT2APOLBBLMUSP2
SCHEMBL14444644 0.86 MEN1 (1.00) MEN1KMT2APOLBBLMUSP2
SCHEMBL30457527 0.86 MEN1 (1.00) MEN1KMT2APOLBBLMUSP2
SCHEMBL30457544 0.83 MEN1 (1.00) MEN1KMT2APOLBBLMUSP2
SCHEMBL25633621 0.83 MEN1 (0.77) MEN1KMT2APOLBBLMUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250051314-A1 SMALL MOLECULE INHIBITORS OF INTERFERON GAMMA SIGNALING PARIS SCIENCES ET LETTRES (FR) 2025-02-13 US disclosed
EP-4444308-A1 SMALL MOLECULE INHIBITORS OF INTERFERON GAMMA SIGNALING Institut Curie (FR) 2024-10-16 EP disclosed
WO-2023104976-A1 SMALL MOLECULE INHIBITORS OF INTERFERON GAMMA SIGNALING INSTITUT CURIE (FR) 2023-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250051314-A1 SMALL MOLECULE INHIBITORS OF INTERFERON GAMMA SIGNALING STAT1, IFNG, IRF2BP2 MEN1 3227/4885KMT2A 2840/4885POLB 1045/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.